Levodopa toxicity and apoptosis

被引:65
作者
Melamed, E
Offen, D
Shirvan, A
Djaldetti, R
Barzilai, A
Ziv, I
机构
[1] Rabin Med Ctr, Dept Neurol, Felsenstein Res Inst, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1002/ana.410440722
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Many in vitro studies have shown that levodopa is a potent toxin which is lethal to various cultured neuronal and non-neuronal cells. The in vitro toxicity of levodopa is linked mainly to its auto-oxidation, which generates a variety of harmful free radical species including superoxide, hydrogen peroxide, and hydroxyl radicals, and also semiquinones and quinones produced via the dopa-melanin metabolic route. Such toxic effects of levodopa can be blocked by co-treatment with antioxidants, particularly thiol-containing compounds. Several studies have shown that levodopa kills cells by triggering apoptosis, an active, intrinsic cell suicide program. Exposure of cultured neurons to levodopa induced the characteristic apoptotic cascade, including cell shrinkage, membrane blebbing, and nuclear and DNA fragmentation. Although levodopa is extremely toxic in vitro, there is no evidence that it damages nigrostriatal dopaminergic neurons in vivo in experimental animals and in patients with Parkinson's disease (PD). Likewise, although there is some evidence for the occurrence of apoptosis in the parkinsonian substantia nigra, it is not known whether levodopa administration is capable of inducing or accelerating programmed cell death of residual pigmented nigral neurons in PD.
引用
收藏
页码:S149 / S154
页数:6
相关论文
共 73 条
[1]
PARKINSONS-DISEASE - PATHOPHYSIOLOGY [J].
AGID, Y .
LANCET, 1991, 337 (8753) :1321-1324
[2]
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease [J].
Ahlskog, JE ;
Uitti, RJ ;
Low, PA ;
Tyce, GM ;
OBrien, JF ;
Nickander, KK .
NEUROLOGY, 1996, 46 (03) :796-801
[3]
Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors [J].
Alexander, T ;
Sortwell, CE ;
Sladek, CD ;
Roth, RH ;
SteeceCollier, K .
CELL TRANSPLANTATION, 1997, 6 (03) :309-315
[4]
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[5]
BASMA AN, 1995, J NEUROCHEM, V64, P825
[6]
DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[7]
SUPPRESSIVE EFFECT OF L-DOPA ON DOPAMINE CELLS REMAINING IN THE VENTRAL TEGMENTAL AREA OF RATS PREVIOUSLY EXPOSED TO THE NEUROTOXIN 6-HYDROXYDOPAMINE [J].
BLUNT, SB ;
JENNER, P ;
MARSDEN, CD .
MOVEMENT DISORDERS, 1993, 8 (02) :129-133
[8]
THE EFFECT OF L-DOPA AND CARBIDOPA TREATMENT ON THE SURVIVAL OF RAT FETAL DOPAMINE GRAFTS ASSESSED BY TYROSINE-HYDROXYLASE IMMUNOHISTOCHEMISTRY AND [H-3] MAZINDOL AUTORADIOGRAPHY [J].
BLUNT, SB ;
JENNER, P ;
MARSDEN, CD .
NEUROSCIENCE, 1991, 43 (01) :95-110
[9]
MECHANISMS OF CELL-DEATH [J].
BOOBIS, AR ;
FAWTHROP, DJ ;
DAVIES, DS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (07) :275-280
[10]
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6